TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
43
|
36
![]() |
36 |
Financial expenses |
111
|
701
|
0 |
Earnings before taxes |
-51
|
-663
|
340 |
EBITDA |
35
|
28
|
27 |
Total assets |
1,221
|
1,314
|
2,322 |
Current assets |
1,208
|
1,296
|
2,298 |
Current liabilities |
85
|
118
|
170 |
Equity capital |
1,136
|
1,196
|
2,065 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.0%
|
91.0%
|
88.9% |
Turnover per employee |
43
|
36
![]() |
36 |
Profit as a percentage of turnover |
-118.6%
|
-1841.7%
|
944.4% |
Return on assets (ROA) |
4.9%
|
2.9%
|
14.6% |
Current ratio |
1421.2%
|
1098.3%
|
1351.8% |
Return on equity (ROE) |
-4.5%
|
-55.4%
|
16.5% |
Change turnover |
8
|
3
|
1 |
Change turnover % |
21%
|
8%
|
2% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.